EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipid changes after interleukin-6 blockade in rheumatoid arthritis: beyond cholesterol elevation toward hepatic inflammatory-lipoprotein remodeling

Na Yuan, Zipei Zhang, Xiancheng Wang, Ting Li

Frontiers in Cardiovascular Medicine · 23.06.2026 · 13

DOI: 10.3389/fcvm.2026.1847053 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 23.06.2026. Verfasst von Na Yuan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis is associated with excess cardiovascular morbidity and mortality despite the frequent presence of relatively low circulating lipid levels during active disease, a phenomenon commonly described as the lipid paradox. Interleukin-6 is central to this paradox because it links synovial inflammation with hepatic acute-phase responses, lipoprotein remodeling, thromboinflammatory pathways, and vascular injury. In this narrative review, we examine how IL-6 blockade reshapes the interpretation of lipid changes in rheumatoid arthritis and whether post-treatment cholesterol elevation should be viewed as isolated metabolic harm or as part of a broader process of hepatic inflammatory-lipoprotein remodeling. Mechanistic and translational evidence suggests, but does not yet prove, that active rheumatoid arthritis is characterized not only by reduced lipid concentrations, but also by dysfunctional high-density lipoprotein, oxidative lipoprotein modification, increased serum amyloid A loading, and vascular inflammation. After IL-6 pathway inhibition, particularly with tocilizumab and sarilumab, total cholesterol and low-density lipoprotein cholesterol often increase early; however, these changes may occur alongside reductions in C-reactive protein, serum amyloid A, lipoprotein(a), fibrinogen, and D-dimers, as well as selected improvements in lipoprotein function. Current hard cardiovascular outcome data generally support cardiovascular neutrality rather than a clear increase in major adverse cardiovascular events, although uncertainty remains for specific outcomes, vascular territories, and patient subgroups. Overall, lipid elevation after IL-6 blockade should prompt contextual cardiovascular risk refinement rather than reflexive interpretation as isolated cholesterol-mediated harm.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular riskhepatic lipid remodelinginterleukin-6 blockadelipid paradoxrheumatoid arthritis

Autor:innen und Institutionen

  • Department of Rheumatology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
  • Graduate Student Administration Office, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
  • Cardiology Department, The Third Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
  • Senile Diseases Department, The Third Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
  • Department of Liver and Stomach Diseases, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.

Zitieren

APA

Yuan, N., Zhang, Z., Wang, X., & Li, T. (2026). Lipid changes after interleukin-6 blockade in rheumatoid arthritis: beyond cholesterol elevation toward hepatic inflammatory-lipoprotein remodeling. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1847053

Vancouver

Yuan N, Zhang Z, Wang X, Li T. Lipid changes after interleukin-6 blockade in rheumatoid arthritis: beyond cholesterol elevation toward hepatic inflammatory-lipoprotein remodeling. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1847053

BibTeX
@article{Yuan2026,
  author = {Yuan, Na and Zhang, Zipei and Wang, Xiancheng and Li, Ting},
  title = {Lipid changes after interleukin-6 blockade in rheumatoid arthritis: beyond cholesterol elevation toward hepatic inflammatory-lipoprotein remodeling},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1847053}
}
Kostenlos starten →